PatientsVille.com Logo

LOSS OF CONSCIOUSNESS and Adderall

PatientsVille

LOSS OF CONSCIOUSNESS Symptoms and Causes

Reye syndrome is a rare illness that can affect the blood, liver, and brain of someone who has recently had a viral infection. It always follows another illness. Although it mostly affects children and teens, anyone can get it. It can develop quickly and without warning. It is most common during flu season. Symptoms include

  • Nausea and vomiting
  • Listlessness
  • Personality change - such as irritability, combativeness or confusion
  • Delirium
  • Convulsions
  • Loss of consciousness

If these symptoms occur soon after a viral illness, seek medical attention immediately. Reye syndrome can lead to a coma and brain death, so quick diagnosis and treatment are critical. Treatment focuses on preventing brain damage. There is no cure.

The cause of Reye syndrome is unknown. Studies have shown that taking aspirin increases the risk of getting it. Because of that, health care professionals now recommend other pain relievers for young patients.

NIH: National Institute of Neurological Disorders and Stroke

Check out the latest treatments for LOSS OF CONSCIOUSNESS

LOSS OF CONSCIOUSNESS treatment research studies

Adderall clinical trials, surveys and public health registries


Find Drug Side Effect reports



Adderall Side Effects

Product Substitution Issue (179)
Headache (168)
Insomnia (149)
Depression (139)
Fatigue (132)
Feeling Abnormal (120)
Aggression (116)
Psychotic Disorder (112)
Suicidal Ideation (110)
Overdose (109)
Abnormal Behaviour (109)
Anxiety (109)
Nausea (106)
Disturbance In Attention (100)
Dizziness (99)
Product Quality Issue (96)
Decreased Appetite (93)
Weight Decreased (92)
Convulsion (87)
Agitation (85)
Heart Rate Increased (42)
Condition Aggravated (42)
Chest Pain (42)
Dyspnoea (40)
Irritability (39)
Prescribed Overdose (38)
Pain (36)
Hallucination (36)
Anger (33)
Palpitations (31)
Paranoia (31)
Tic (28)
Off Label Use (28)
Abdominal Pain Upper (27)
Vomiting (27)
Malaise (27)
Loss Of Consciousness (26)
Fall (26)
Mania (24)
Hyperhidrosis (24)
Blood Pressure Increased (24)
Anorexia (23)
Tremor (23)
Somnolence (22)
Abdominal Pain (22)
Diarrhoea (22)
Weight Increased (21)
Confusional State (21)
Suicide Attempt (20)
Syncope (20)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Getting headaches, dehydration (drink alot of water) and just plain miserable inside. Want to get off of it but what to do?? <a href='http://www.honeywellcentral.com/thermostats'>Honeywell Thermostats</a>

16, ADHD, hate my dependency on adderall, depression, random euphoria, aggression, slight tics, restlessness, irritability, antisocial, anger, all day the only thing i'm able to think about is the list of shit that needs to get done and if it's a lon

52 years of age. Diagnosed with ADHD. Treated with Adderall XR 15mg. Developed Interstitial Cystitis after about 3 months of use, yet not diagnosed for 2 years.

Cramping underneath pinky

Doctor put me on 25mg adderallxr 1 time a day 2 years ago.....my son has aspergers and since I have been on it I am experiencing musle weakness, irritation at night and headaches. I am 60 and have my own business and dread the nights becaus

Does adderall effect how quickly (or slowly) alcohol is absorbed in your system?

Does anyone experience bone problems on Adderal?

How does a dr. know you need aderall?

I am normally, at least I'd like to remember myself as a calm caring person. Anyway, I've been on Adderall for a little over a year now. Though, there are circumstances in my life that may have caused me to be upset, I have become very angry, mood

I have been taking adderall intermitedly for about 4 years but about 3 weeks i finialy decided to do what my doctor wanted and started taking it every day... i have ADHD and adderall has generally been perfect for me. but in the past week m

I took Mucinex DM 1200mg once at 10:30 pm and again at 10:30 am. By noon I wasnt functional at all, I had severe loss of focus, my eyes were dilated, and I was really slow, on top of the usual side effects of being jittery and nauseous. Since

I have been put on Molipaxin 3 weeks ago, I have dry mouth, hair loss and my panic attacks were showing no signs of improvement. Dr increased it to 100mg and put me onto Lamictin. I am not bi polar nor epileptic. My disorder ist algora phoebia. I a

leg cramps, hair loss Would it be better to take Lisinopril?

Have taken hydrea for a year because my spleen had increased in size. I have noticed increased loss of memory and some confusion for the past couple of months. I take 500 mg every other day and 1000 mg every other day.

I am having cramps, muscle pain, memory loss, I have been on Revlmid for about 1 year. Does anybody else my age have this disease, I am only 46 yr woman.

I have experienced weight loss of a pound a month for the last 2 years, since taking 100 mcg per day. My dr. can find no cause for this loss. I also have taken Metformin for about the same amount of time.

I have seen a significant loss of hair after about three months. I went to my dermatologist and told her that I feel that it is from Solodyn and she sent me to have blood work done thinking I may be anemic or I have a thyroid problem.

Anon- I would say the weed would cause the MOST memory loss used over time also depending on how strong it is ie, (haze, kush....dro...regs from 60's with seeds) THE STONGER it is the faster the brain cells go! As far as the valium/dia

<strong>Found Celepram effective at the end of the 3rd week. Effectiveness lasted for around 14 days. Following period i experienced continualled short term memory loss, hallucinations of seeing stars, skin irritated rash, shortness of breath &

3 months child red all over, staring, screaming high pitched cry, tracking red lines from injection site, lowered consciousness, screaming for more than 2 hours worse upon lying down. Would not breastfeed for 8 hours. Dosed exhuasted and awoke with h

LOSS OF CONSCIOUSNESS Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Not yet recruiting Adderall XR and Processing Speed in Multiple Sclerosis (MS)
Conditions: Impaired Processing Speed;   Cognitive Impairment;   Multiple Sclerosis
Interventions: Drug: Adderall XR 5mg;   Drug: Adderall XR 10 mg;   Drug: Placebo
Outcome Measures: Change in score of Paced Auditory Serial Addition Test (PASAT);   Change in Score of Symbol Digit Modalities Test (SDMT);   Change in Score of Stroop Colour Word Test;   Blood Pressure;   Heart Rate
2 Recruiting Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence
Condition: Cocaine Dependence
Interventions: Drug: Adderall-ER;   Drug: Topiramate;   Other: Placebo
Outcome Measures: Three weeks of Cocaine abstinence;   Proportion of negative urine samples
3 Recruiting Stimulant Enhancement of Well-Being Therapy for Depression
Condition: Major Depressive Disorder
Interventions: Drug: Amphetamine-dextroamphetamine (AMPH);   Drug: Placebo;   Behavioral: Well-being therapy
Outcome Measures: Change in Hamilton-Depression Rating Scale(SIGH-D)-17 items;   Change in Hamilton-Depression Rating Scale(SIGH-D)-31 item;   Change in Psychological Well-being Scale (PWB);   Change in the Snaith-Hamilton Pleasure Scale (SHAPS);   Change in Behavioral inhibition/activation scale (BIS/BAS);   Change in Positive and Negative Affective Scale (PANAS);   Change in functioning on Short Form-12(SF-12)
4 Recruiting Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Behavioral: Academic and Organization skills;   Behavioral: Parent Training;   Behavioral: Social Skills Training;   Drug: Long-acting stimulant
Outcome Measures: Attention Deficit Hyperactivity Disorder (ADHD) symptomatology (measured via Conners' Global Index - Parent and Teacher Version);   Social skills (measured via Parent and Teacher Social Skills Rating Scale);   Academic achievement (measured via Wechsler Individual Achievement Test (WIAT));   Emotional and symptomatic functioning (measured via the Achenbach Child Behavior Check List (CBCL));   Overall functioning (measured via the Weiss Functional Impairment Scale (WFIRS));   Overall functioning (measured via the Clinical Global Impression Scale (CGI))
5 Recruiting Adjunctive Mixed Salts Amphetamine (MSA) for Depressed Adults With Incomplete Response to Current Antidepressant Therapy (ADT)
Condition: Major Depressive Disorder
Intervention: Drug: mixed salts amphetamine
Outcome Measures: Change in scores on the Massachusetts General Hospital Cognitive and Physical Functioning Questionaire;   Change in scores on the Montgomery Asberg Depression Rating Scale;   Change in scores on the Quick Inventory of Depressive Symptomatology Self Report 16
6 Recruiting Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits
Conditions: Attention Deficit Hyperactivity Disorder (ADHD);   Deficient Emotional Self-Regulation (DESR)
Interventions: Drug: ADHD Medication;   Drug: Omega-3 Fatty Acids
Outcome Measures: Efficacy assessed by mean change from baseline to endpoint on the BRIEF-A Emotional Control scale;   Efficacy measured by mean change from baseline to endpoint on AISRS total score;   Efficacy measured by mean change from baseline to endpoint on CGI;   Efficacy measured by mean change from baseline to endpoint on BRIEF-A subscales;   Efficacy measured by mean change from baseline to endpoint on GAF
7 Recruiting Interventions for Children With Attention and Reading Disorders
Conditions: Attention Deficit Hyperactivity Disorder;   Reading Disabilities
Interventions: Drug: Methylphenidate;   Behavioral: Intensive reading instruction;   Behavioral: Parent Training;   Drug: Mixed Salt Amphetamine;   Drug: Atomoxetine;   Drug: Guanfacine
Outcome Measures: Wechsler Individual Achievement Test of Word Reading and Pseudoword Decoding;   Swanson, Nolan, and Pelham checklist for DSM-IV;   Stop-Signal Test;   Test of Word Reading Efficiency;   Wechsler Individual Achievement Test of Reading Comprehension;   Dynamic Indicators of Basic Early Literacy Skills Oral Reading Fluency
8 Not yet recruiting A Sequenced Behavioral and Medication Intervention for Cocaine Dependence
Condition: Cocaine Dependence
Interventions: Behavioral: Computer-assisted behavior therapy;   Drug: Mixed amphetamine salts;   Drug: Computer-assisted therapy plus placebo (for mixed amphetamine salts)
Outcome Measures: Three weeks of cocaine abstinence;   Proportion of cocaine positive urines
9 Recruiting Efficacy of Intuniv Extended Release as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Guanfacine extended release;   Drug: Placebo
Outcome Measures: To evaluate the effect of adjunctive INTUNIV extended release treatment on executive function as assessed by the BRIEF-parent questionnaires;   To evaluate the effect of adjunctive INTUNIV extended release treatment on quality of life as assessed by the KINDL®-child and KINDL®-parent questionnaires.;   To examine the congruency of the perceived effect of treatment on EF and quality of life from the perspective of the subject, parent, and teacher.;   To evaluate the effect of adjunct therapy on ADHD symptom control as assessed by the ADHD Rating Scale (ADHD-RS-IV) and Clinical Global Impression (CGI) of Severity (CGI-S) and of Improvement (CGI-I) questionnaires.;   To compare the percentage of subjects experiencing suicidal ideation, suicidal behaviour and self-injurious behaviour without suicidal intent and incident of Serious Adverse Events in each treatment arm
10 Recruiting IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents
Conditions: ADHD;   HIV
Intervention:
Outcome Measure: Estimation of steady-state oral clearance (Cl/F) for each psychiatric study medication is the primary outcome.